Narmada Health Mission Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 11-01-2025
- Paid Up Capital ₹ 0.10 M
as on 11-01-2025
- Company Age 4 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.53 M
as on 11-01-2025
- Revenue 464.28%
(FY 2022)
- Profit 685.02%
(FY 2022)
- Ebitda 719.86%
(FY 2022)
- Net Worth 666.98%
(FY 2022)
- Total Assets 50.39%
(FY 2022)
About Narmada Health Mission
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.53 M.
Dhirajkumar Sathe, Sukdeo Bhoi, and Manisha Sathe serve as directors at the Company.
- CIN/LLPIN
U85320GJ2020PTC117244
- Company No.
117244
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Oct 2020
- Date of AGM
26 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Bharuch, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Narmada Health Mission?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dhirajkumar Sathe  | Managing Director | 12-Oct-2020 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sukdeo Bhoi | Director | 12-Oct-2020 | Current |
| Manisha Sathe | Additional Director | 13-Feb-2024 | Current |
Financial Performance of Narmada Health Mission.
Narmada Health Mission Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 464.28% increase. The company also saw a substantial improvement in profitability, with a 685.02% increase in profit. The company's net worth Soared by an impressive increase of 666.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Narmada Health Mission?
In 2021, Narmada Health Mission had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
₹2.53 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Feb 2024 | Others | ₹0.25 M | Open |
| 20 Jan 2023 | Others | ₹0.58 M | Open |
| 24 Oct 2022 | Others | ₹1.70 M | Open |
How Many Employees Work at Narmada Health Mission?
Narmada Health Mission has a workforce of 24 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Narmada Health Mission, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Narmada Health Mission's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.